SEGMENT INFORMATION

6 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

SEGMENT INFORMATION

7. SEGMENT INFORMATION

We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2016.

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2017		2016		2017		2016
Revenue:
Service	$	4,962	$	4,053	$	10,226	$	8,108
Product		1,397		1,286		2,307		2,126
	$	6,359	$	5,339	$	12,533	$	10,234
Operating income (loss):
Service	$	445	$	(279)	$	739	$	(598)
Product		110		17		(90)		(193)
	$	555	$	(262)	$	649	$	(791)
Interest expense		(134)		(70)		(210)		(136)
Decrease in fair value of warrant liability		—		79		—		168
Other income		1		—		2		1
Income (loss) before income taxes	$	422	$	(253)	$	441	$	(758)